Biotechnology

BioRay's ROR1-Targeting Dual-Epitope ADC Drug BR111 Receives Formal Clinical Trial Approval from NMPA

SHANGHAI, Feb. 10, 2025 /PRNewswire/ -- On December 19, 2024, BioRay Pharmaceutical Co., Ltd. ("BioRay") announced that the National Medical Products Administration (NMPA) has accepted the clinical trial application for its self-developed Class 1 innovative therapeutic biological product, BR111 f...

2025-02-10 15:32 2179

NUS scientists develop realistic 'micro-gut' model to study the relationship between gut microbes and human diseases

The 3D scalable 'gut-on-a-chip' model enables real-time visualisation of the interactions of gut microbes and the human intestine SINGAPORE, Feb. 10, 2025 /PRNewswire/ -- In a breakthrough for the advanced study of gut health, scientists from theNational University of Singapore (NUS) have develo...

2025-02-10 13:14 2199

CStone Announces Inclusion of Cejemly® (sugemalimab) as a First-Line Combination Therapy for NSCLC in ESMO Guideline

SUZHOU, China, Feb. 9, 2025 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of anti-cancer therapies, today announced that its key product, Cejemly® (sugemalimab), has been included in the Europe...

2025-02-10 12:20 2324

CARsgen's First Enrolled Subject in the THANK-u Plus™ Platform-Based Allogeneic CAR-T Trial Achieves sCR at Week 4

SHANGHAI, Feb. 9, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that the first subject treated with an allogeneic BCMA CAR-T therapy d...

2025-02-10 08:29 2839

'The convergence between of AI and the Biology' LG Creates "Next-Generation Protein Structure Prediction AI" for Drug Discovery

SEOUL, South Korea, Feb. 7, 2025 /PRNewswire/ -- On the 5th, LG AI Research signed a joint research agreement at the Global Lounge of LG Science Park in Magok, Gangseo-gu,Seoul, with Prof. Min-Kyung Baek from the school of Biological Sciences at SeoulNational University to develop a "next-generat...

2025-02-07 21:00 4355

GCCL Wins 2025 Asia-Pacific Customer Value Leadership Award by Frost & Sullivan

-      GCCL's "One-Stop Lab Solution" sets the industry benchmark with unmatched competitiveness and a dedication to global excellence. -      Continuing its growth as a globally recognized leader in clinical sample analysis, driven by customer-centric values. YONGIN, South Korea, Feb. 7, 2025 /...

2025-02-07 09:31 2518

Akeso Announces the Completion of Patient Enrollment in the Phase III Clinical Trial (HARMONi-6) Comparing Ivonescimab and Tislelizumab for First-Line Treatment of Sq-NSCLC

HONG KONG, Feb. 5, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company")  is excited to announce the completion of patient enrollment in the global Phase III clinical trial (HARMONi-6/AK112-306) evaluating ivonescimab, its independently developed PD-1/VEGF bispecific antibody. Thi...

2025-02-06 09:28 2474

Actinogen announces new and unique nonproprietary name of 'emestedastat' for Xanamem

Late-stage Alzheimer's trial opens 10 new sites in USA, with results due in 2025 and 2026 SYDNEY, Feb. 5, 2025 /PRNewswire/ -- Actinogen Medical Limited (ASX: ACW) announces that the World Health Organization (WHO) has granted the nonproprietary name of 'emestedastat' to Actinogen for its Xaname...

2025-02-05 22:18 2857

I Peace establishes and offers low immunoreaction risk GMP iPS Cells

Three lines of GMP iPS Cells derived from type O female blood are now offered  as off-the-shelf product PALO ALTO, Calif., Feb. 5, 2025 /PRNewswire/ -- Leading GMP cell CDMO I Peace, Inc. (https://ipeace.com/en/ ), specializing in induced pluripotent stem cells (iPSCs) and...

2025-02-05 22:00 2464

From 0 to 100 Trillion: The Rise of Sanyou Bio's Intelligent Molecule Library

SHANGHAI, Feb. 5, 2025 /PRNewswire/ -- In the field of biopharmaceuticals, every technological innovation has the potential to revolutionize treatment strategies. Sanyou Bio's Intelligent Hundred-Trillion Molecule Library (AI-STAL) has emerged from scratch as a shining star, forged through a deca...

2025-02-05 18:00 2102

China Medical University and Healthcare System Pioneers AI-Driven Drug Discovery and Allogeneic CAR-T Therapy: A Groundbreaking Leap in Cancer Treatment

TAICHUNG, Feb. 5, 2025 /PRNewswire/ -- Healthcare Expo Taiwan is a professional-oriented exposition involving healthcare, information/communication, technology, biopharmaceutical and medical device industries. Attended by healthcare professionals from all over the world, the Expo showcases the l...

2025-02-05 13:00 2439

Sequins™ Announces Availability of First Products - Bolsters Team for Commercialization

SAN FRANCISCO, Feb. 4, 2025 /PRNewswire/ -- Sequins, a newly-funded start-up in the next generation sequencing (NGS) ecosystem, announced today the availability of their first commercial products – the Sequins Metagenomics Core Control and Whole Genome Sequencing Core Control Sets, along with an ...

2025-02-05 00:00 2034

GC Labs strengthens global ties and explores new opportunities at Medlab Middle East 2025

YONGIN, South Korea, Feb. 4, 2025 /PRNewswire/ -- GC Labs, a leading clinical laboratory inSouth Korea, announced the successful completion of the second day of the Medlab Middle East 2025, which is being held at theDubai World Trade Centre (DWTC), UAE betweenFebruary 3-6.

2025-02-04 14:56 2518

Lunit Partners with SITC to Launch Exclusive Research Program Featuring Advanced AI Technology for SITC Members

Lunit SCOPE® IO now available to SITC members for AI-powered TME profiling, in a collaborative effort to advance cancer immunotherapy SEOUL, South Korea, Feb. 3, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, has en...

2025-02-03 22:00 3233

Nona Biosciences Announces Strategic Collaboration with Invetx for Next-Generation Animal Health Biotherapeutics Discovery

CAMBRIDGE, Mass., Feb. 3, 2025 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to I TM), announced today that it has entered into a strategic collaboration with Invetx, Inc. ("Invetx"), aBoston-based animal biotechnology company...

2025-02-03 20:00 2332

Advanced Aesthetic Technologies, Inc. is pleased to announce the approval of Algeness® VL agarose facial injection filler for marketing in China

AAT announces additional significant updates RADNOR, Pa., Jan. 29, 2025 /PRNewswire/ -- Advanced Aesthetic Technologies, Inc. ("AAT") announced today that their partner inChina has obtained approval to market their unique dermal filler Algeness® VL agarose facial injection filler, a 2.5% agarose...

2025-01-29 14:00 3563

Bloomage Joins the United Nations Global Compact

PARSIPPANY, N.J., Jan. 27, 2025 /PRNewswire/ -- Bloomage, a global leader in hyaluronic acid and other bioactive innovations, officially joined the United Nations Global Compact (UNGC). This commitment further reflects Bloomage's on-going efforts in global sustainable development.

2025-01-27 21:00 2766

Akeso's Gumokimab Monoclonal Antibody (IL-17) New Drug Application for the Treatment of Moderate to Severe Psoriasis Accepted by NMPA

HONG KONG, Jan. 26, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that the New Drug Application (NDA) of its internally-developed IL-17-targeting monoclonal antibody gumokimab (AK111) has been accepted by the Center for Drug Evaluation (CDE) of the N...

2025-01-27 09:53 2869

Nuevocor Welcomes Andreas Wallnöfer as Chairman of the Board of Directors

SINGAPORE and PHILADELPHIA, Jan. 24, 2025 /PRNewswire/ -- Nuevocor , an IND-stage biotechnology company dedicated to developing functional cures to treat cardiomyopathies with aberrant mechanobiology, today announces the appointment ofDr. Andreas Wallnöfer as Chairman ...

2025-01-24 22:00 4976

NUS researchers pioneer DNA-tagged gold nanoparticles for targeted cancer treatment

Using DNA barcoding, the novel technique tracks and optimises gold nanoparticles for precise drug delivery to tumours, advancing cancer therapies that are safer and more effective SINGAPORE, Jan. 24, 2025 /PRNewswire/ -- A team of researchers from the National University of Singapore (NUS) has d...

2025-01-24 15:55 3250
1 ... 31323334353637 ... 155

Week's Top Stories